Separation will unlock potential of both companies to pursue distinct growth and value-creation strategies
The new Nutrition company will be a global leader in the rapidly growing healthy nutrition market, with a portfolio of iconic, category-leading brands, including Similac, PediaSure, Pedialyte, Glucerna and Ensure
Abbott will have accelerated sales growth and an expanded margin profile
Abbott intends to separate its Nutrition business through a tax-free distribution to Abbott shareholders
Separation expected to be completed by the end of 2027
Abbott (NYSE: ABT), the global healthcare leader, today announced its intention to separate its Nutrition business into an independent, publicly traded company that will be a global leader in the rapidly expanding healthy nutrition market with approximately $8.5 billion in annual sales and a portfolio of iconic brands.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.